Amphora™ completed a phase III contraceptive clinical trial.

Read More


Amphora™ offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem CBO Louis Villalba Announced as Guest Speaker in Stanford’s Global Biodesign Course

May 6, 2015

Louis Villalba, Chief Business Officer for biotechnology company Evofem, Inc., will be a guest speaker in the Stanford University Biodesign program on May 6, 2015. Mr. Villalba will be speaking to students in the class Global Biodesign: Medical Technology in an International Context. The course focuses on the development and commercialization of healthcare products in…

More News